$100m m/c, page-4

Management are playing a nice game of chess at the moment, with some strategic moves - just a reminder that they are putting it out there and will be following-up their pre-christmas results with a presentation at the BIO CEO and Investor Conference in New York in February.

http://news.thomasnet.com/companystory/BIO-announces-presenting-companies-for-2012-conference-606226

BIO CEO & Investor Conference 2012

WASHINGTON--The Biotechnology Industry Organization (BIO) today announced the initial selection of presenting companies for the 14th Annual BIO CEO & Investor Conference to be held February 13 - 14, 2012 in New York City.

"As the largest independent investor conference focused solely on publicly-traded biotechnology companies, this event provides an ideal platform for companies to present their story to investors, analysts, and potential corporate partners," said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO.

Presenting companies are hand-selected for the event, and consist of a selection of mid- to large-cap established public companies from around the globe, which typically have a clinical stage program centered on therapeutics, molecular diagnostics, or a platform technology, as well as an upcoming clinical, regulatory, or corporate catalyst. A total of 140 companies will present their story at the conference in February.

The CEO & Investor Conference provides a forum for investors, industry analysts and senior biotechnology executives to shape the future investment landscape of the industry. Investors attend to network with management from the top biotechnology companies, evaluate fresh investment opportunities, attend candid panel discussions and get an overview of the industry and key issues affecting investments."